Ontology type: schema:ScholarlyArticle Open Access: True
2021-10-09
AUTHORSMadeeha Shahzad Lodhi, Muhammad Tahir Khan, Saira Aftab, Zahoor Qadir Samra, Heng Wang, Dong Qing Wei
ABSTRACTBackgroundTheranostic nanomedicines contain a nanovehicle that has fluorescent properties and can be used for diagnostic, therapeutic and prognostic purposes. The transferrin receptor expression is 1000-fold higher in rapidly growing cancer cells as compared to the normal cells and, therefore, can be used in targeted drug delivery systems. The objective of the present study was to design a novel targeted gold nanoparticle (GNPs)-based theranostic formulation for gastrointestinal (GI) tract-related cancers. The synthesized GNPs were conjugated to transferrin and doxorubicin both separately and collectively to check their cytotoxic properties. The in vitro cytotoxicity of nanocomposites was observed against colon cancer cell line HCT-116. The doxorubicin conjugated nanocomposites showed almost the same cytotoxicity, but more effect at later hours (h). The IC50 and IC100 were 50 µg/ml and 250 µg/ml, respectively, equivalent to the doxorubicin weight for GNP theranostic nanomedicine.ResultsThe maximum effect was observed after 12 h and nanomedicines were still active after 72 h of treatment. Our in vivo data proved that nanomedicine crossed all the barriers and was successfully delivered to the tumour cells. Theranostic nanomedicine’s (TNM) effect on body weight and survival rate on mice was many folds better than mice in pure doxorubicin group. It also showed almost 80% survival rate on day 40. The in vivo and in vitro results show the effects of prolonged drug release and the nanomedicine was not toxic to vital organs of the animal.ConclusionThis is one of its kind studies in which a novel targeted nanomedicines approach was formulated for therapeutic as well as prognostic purposes against GI tract cancer.Graphic Abstract More... »
PAGES26
http://scigraph.springernature.com/pub.10.1186/s12645-021-00098-4
DOIhttp://dx.doi.org/10.1186/s12645-021-00098-4
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1141763172
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Oncology and Carcinogenesis",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "Institute of Molecular Biology and Biotechnology (IMBB), The University of Lahore, Defence Road Lahore, Postal code: 58810, Lahore, Pakistan",
"id": "http://www.grid.ac/institutes/grid.440564.7",
"name": [
"Institute of Molecular Biology and Biotechnology (IMBB), The University of Lahore, Defence Road Lahore, Postal code: 58810, Lahore, Pakistan"
],
"type": "Organization"
},
"familyName": "Lodhi",
"givenName": "Madeeha Shahzad",
"id": "sg:person.015203065237.50",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015203065237.50"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Institute of Molecular Biology and Biotechnology (IMBB), The University of Lahore, Defence Road Lahore, Postal code: 58810, Lahore, Pakistan",
"id": "http://www.grid.ac/institutes/grid.440564.7",
"name": [
"Institute of Molecular Biology and Biotechnology (IMBB), The University of Lahore, Defence Road Lahore, Postal code: 58810, Lahore, Pakistan"
],
"type": "Organization"
},
"familyName": "Khan",
"givenName": "Muhammad Tahir",
"id": "sg:person.015572452620.25",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015572452620.25"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Institute of Molecular Biology and Biotechnology (IMBB), The University of Lahore, Defence Road Lahore, Postal code: 58810, Lahore, Pakistan",
"id": "http://www.grid.ac/institutes/grid.440564.7",
"name": [
"Institute of Molecular Biology and Biotechnology (IMBB), The University of Lahore, Defence Road Lahore, Postal code: 58810, Lahore, Pakistan"
],
"type": "Organization"
},
"familyName": "Aftab",
"givenName": "Saira",
"id": "sg:person.012323352117.10",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012323352117.10"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Institute of Biochemistry and Biotechnology, University of the Punjab, Lahore, Pakistan",
"id": "http://www.grid.ac/institutes/grid.11173.35",
"name": [
"Institute of Biochemistry and Biotechnology, University of the Punjab, Lahore, Pakistan"
],
"type": "Organization"
},
"familyName": "Samra",
"givenName": "Zahoor Qadir",
"id": "sg:person.01215704533.26",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01215704533.26"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "State Key Laboratory of Microbial Metabolism, School of Life Sciences and Biotechnology, Shanghai, China",
"id": "http://www.grid.ac/institutes/grid.16821.3c",
"name": [
"State Key Laboratory of Microbial Metabolism, School of Life Sciences and Biotechnology, Shanghai, China"
],
"type": "Organization"
},
"familyName": "Wang",
"givenName": "Heng",
"type": "Person"
},
{
"affiliation": {
"alternateName": "Peng Cheng Laboratory, Vanke Cloud City Phase I Building 8, Xili Street, Nashan District, 518055, Shenzhen, Guangdong, People\u2019s Republic of China",
"id": "http://www.grid.ac/institutes/grid.508161.b",
"name": [
"State Key Laboratory of Microbial Metabolism, School of Life Sciences and Biotechnology, Shanghai, China",
"Joint Laboratory of International Cooperation in Metabolic and Developmental Sciences, Ministry of Education, Shanghai Jiao Tong University, 200240, Shanghai, China",
"Peng Cheng Laboratory, Vanke Cloud City Phase I Building 8, Xili Street, Nashan District, 518055, Shenzhen, Guangdong, People\u2019s Republic of China"
],
"type": "Organization"
},
"familyName": "Wei",
"givenName": "Dong Qing",
"id": "sg:person.0711767431.18",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0711767431.18"
],
"type": "Person"
}
],
"citation": [
{
"id": "sg:pub.10.1038/srep21225",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1019159708",
"https://doi.org/10.1038/srep21225"
],
"type": "CreativeWork"
}
],
"datePublished": "2021-10-09",
"datePublishedReg": "2021-10-09",
"description": "BackgroundTheranostic nanomedicines contain a nanovehicle that has fluorescent properties and can be used for diagnostic, therapeutic and prognostic purposes. The transferrin receptor expression is 1000-fold higher in rapidly growing cancer cells as compared to the normal cells and, therefore, can be used in targeted drug delivery systems. The objective of the present study was to design a novel targeted gold nanoparticle (GNPs)-based theranostic formulation for gastrointestinal (GI) tract-related cancers. The synthesized GNPs were conjugated to transferrin and doxorubicin both separately and collectively to check their cytotoxic properties. The in vitro cytotoxicity of nanocomposites was observed against colon cancer cell line HCT-116. The doxorubicin conjugated nanocomposites showed almost the same cytotoxicity, but more effect at later hours (h). The IC50 and IC100 were 50\u00a0\u00b5g/ml and 250\u00a0\u00b5g/ml, respectively, equivalent to the doxorubicin weight for GNP theranostic nanomedicine.ResultsThe maximum effect was observed after 12\u00a0h and nanomedicines were still active after 72\u00a0h of treatment. Our in vivo data proved that nanomedicine crossed all the barriers and was successfully delivered to the tumour cells. Theranostic nanomedicine\u2019s (TNM) effect on body weight and survival rate on mice was many folds better than mice in pure doxorubicin group. It also showed almost 80% survival rate on day 40. The in vivo and in vitro results show the effects of prolonged drug release and the nanomedicine was not toxic to vital organs of the animal.ConclusionThis is one of its kind studies in which a novel targeted nanomedicines approach was formulated for therapeutic as well as prognostic purposes against GI tract cancer.Graphic Abstract",
"genre": "article",
"id": "sg:pub.10.1186/s12645-021-00098-4",
"inLanguage": "en",
"isAccessibleForFree": true,
"isFundedItemOf": [
{
"id": "sg:grant.8943040",
"type": "MonetaryGrant"
}
],
"isPartOf": [
{
"id": "sg:journal.1042272",
"issn": [
"1868-6958",
"1868-6966"
],
"name": "Cancer Nanotechnology",
"publisher": "Springer Nature",
"type": "Periodical"
},
{
"issueNumber": "1",
"type": "PublicationIssue"
},
{
"type": "PublicationVolume",
"volumeNumber": "12"
}
],
"keywords": [
"theranostic nanomedicine",
"cytotoxicity of nanocomposites",
"synthesized GNPs",
"drug delivery systems",
"conjugated nanocomposite",
"theranostic formulations",
"gold nanoparticles",
"nanomedicine",
"nanomedicine approaches",
"drug delivery",
"delivery system",
"tract cancer",
"drug release",
"nanocomposites",
"survival rate",
"prognostic purposes",
"fluorescent properties",
"gastrointestinal tract cancer",
"GI tract cancers",
"same cytotoxicity",
"transferrin receptor expression",
"nanoparticles",
"Graphic abstract",
"doxorubicin group",
"nanovehicles",
"receptor expression",
"cancer cell line HCT-116",
"cell line HCT-116",
"body weight",
"colon cancer cell line HCT-116",
"vital organs",
"tumor cells",
"day 40",
"novel formulation",
"cancer cells",
"cancer",
"GNP",
"normal cells",
"maximum effect",
"vivo data",
"mice",
"cytotoxicity",
"HCT-116",
"present study",
"properties",
"novel",
"cells",
"delivery",
"cytotoxic properties",
"doxorubicin",
"ConclusionThis",
"IC100",
"effect",
"treatment",
"weight",
"IC50",
"vivo",
"organs",
"later hours",
"study",
"animals",
"rate",
"hours",
"transferrin",
"formulation",
"more effect",
"group",
"expression",
"release",
"kind study",
"purpose",
"system",
"barriers",
"objective",
"approach",
"folds",
"data",
"results",
"Abstract"
],
"name": "A novel formulation of theranostic nanomedicine for targeting drug delivery to gastrointestinal tract cancer",
"pagination": "26",
"productId": [
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1141763172"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1186/s12645-021-00098-4"
]
}
],
"sameAs": [
"https://doi.org/10.1186/s12645-021-00098-4",
"https://app.dimensions.ai/details/publication/pub.1141763172"
],
"sdDataset": "articles",
"sdDatePublished": "2022-05-10T10:31",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-springernature-scigraph/baseset/20220509/entities/gbq_results/article/article_909.jsonl",
"type": "ScholarlyArticle",
"url": "https://doi.org/10.1186/s12645-021-00098-4"
}
]
Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s12645-021-00098-4'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s12645-021-00098-4'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s12645-021-00098-4'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s12645-021-00098-4'
This table displays all metadata directly associated to this object as RDF triples.
188 TRIPLES
22 PREDICATES
105 URIs
96 LITERALS
6 BLANK NODES
Subject | Predicate | Object | |
---|---|---|---|
1 | sg:pub.10.1186/s12645-021-00098-4 | schema:about | anzsrc-for:11 |
2 | ″ | ″ | anzsrc-for:1112 |
3 | ″ | schema:author | N02e44a52e8a0456193f6f274d93ec0fe |
4 | ″ | schema:citation | sg:pub.10.1038/srep21225 |
5 | ″ | schema:datePublished | 2021-10-09 |
6 | ″ | schema:datePublishedReg | 2021-10-09 |
7 | ″ | schema:description | BackgroundTheranostic nanomedicines contain a nanovehicle that has fluorescent properties and can be used for diagnostic, therapeutic and prognostic purposes. The transferrin receptor expression is 1000-fold higher in rapidly growing cancer cells as compared to the normal cells and, therefore, can be used in targeted drug delivery systems. The objective of the present study was to design a novel targeted gold nanoparticle (GNPs)-based theranostic formulation for gastrointestinal (GI) tract-related cancers. The synthesized GNPs were conjugated to transferrin and doxorubicin both separately and collectively to check their cytotoxic properties. The in vitro cytotoxicity of nanocomposites was observed against colon cancer cell line HCT-116. The doxorubicin conjugated nanocomposites showed almost the same cytotoxicity, but more effect at later hours (h). The IC50 and IC100 were 50 µg/ml and 250 µg/ml, respectively, equivalent to the doxorubicin weight for GNP theranostic nanomedicine.ResultsThe maximum effect was observed after 12 h and nanomedicines were still active after 72 h of treatment. Our in vivo data proved that nanomedicine crossed all the barriers and was successfully delivered to the tumour cells. Theranostic nanomedicine’s (TNM) effect on body weight and survival rate on mice was many folds better than mice in pure doxorubicin group. It also showed almost 80% survival rate on day 40. The in vivo and in vitro results show the effects of prolonged drug release and the nanomedicine was not toxic to vital organs of the animal.ConclusionThis is one of its kind studies in which a novel targeted nanomedicines approach was formulated for therapeutic as well as prognostic purposes against GI tract cancer.Graphic Abstract |
8 | ″ | schema:genre | article |
9 | ″ | schema:inLanguage | en |
10 | ″ | schema:isAccessibleForFree | true |
11 | ″ | schema:isPartOf | N1206493e424342ddbbdef0ee868a0464 |
12 | ″ | ″ | N79d7d0de8f644f939a085fc598e75466 |
13 | ″ | ″ | sg:journal.1042272 |
14 | ″ | schema:keywords | Abstract |
15 | ″ | ″ | ConclusionThis |
16 | ″ | ″ | GI tract cancers |
17 | ″ | ″ | GNP |
18 | ″ | ″ | Graphic abstract |
19 | ″ | ″ | HCT-116 |
20 | ″ | ″ | IC100 |
21 | ″ | ″ | IC50 |
22 | ″ | ″ | animals |
23 | ″ | ″ | approach |
24 | ″ | ″ | barriers |
25 | ″ | ″ | body weight |
26 | ″ | ″ | cancer |
27 | ″ | ″ | cancer cell line HCT-116 |
28 | ″ | ″ | cancer cells |
29 | ″ | ″ | cell line HCT-116 |
30 | ″ | ″ | cells |
31 | ″ | ″ | colon cancer cell line HCT-116 |
32 | ″ | ″ | conjugated nanocomposite |
33 | ″ | ″ | cytotoxic properties |
34 | ″ | ″ | cytotoxicity |
35 | ″ | ″ | cytotoxicity of nanocomposites |
36 | ″ | ″ | data |
37 | ″ | ″ | day 40 |
38 | ″ | ″ | delivery |
39 | ″ | ″ | delivery system |
40 | ″ | ″ | doxorubicin |
41 | ″ | ″ | doxorubicin group |
42 | ″ | ″ | drug delivery |
43 | ″ | ″ | drug delivery systems |
44 | ″ | ″ | drug release |
45 | ″ | ″ | effect |
46 | ″ | ″ | expression |
47 | ″ | ″ | fluorescent properties |
48 | ″ | ″ | folds |
49 | ″ | ″ | formulation |
50 | ″ | ″ | gastrointestinal tract cancer |
51 | ″ | ″ | gold nanoparticles |
52 | ″ | ″ | group |
53 | ″ | ″ | hours |
54 | ″ | ″ | kind study |
55 | ″ | ″ | later hours |
56 | ″ | ″ | maximum effect |
57 | ″ | ″ | mice |
58 | ″ | ″ | more effect |
59 | ″ | ″ | nanocomposites |
60 | ″ | ″ | nanomedicine |
61 | ″ | ″ | nanomedicine approaches |
62 | ″ | ″ | nanoparticles |
63 | ″ | ″ | nanovehicles |
64 | ″ | ″ | normal cells |
65 | ″ | ″ | novel |
66 | ″ | ″ | novel formulation |
67 | ″ | ″ | objective |
68 | ″ | ″ | organs |
69 | ″ | ″ | present study |
70 | ″ | ″ | prognostic purposes |
71 | ″ | ″ | properties |
72 | ″ | ″ | purpose |
73 | ″ | ″ | rate |
74 | ″ | ″ | receptor expression |
75 | ″ | ″ | release |
76 | ″ | ″ | results |
77 | ″ | ″ | same cytotoxicity |
78 | ″ | ″ | study |
79 | ″ | ″ | survival rate |
80 | ″ | ″ | synthesized GNPs |
81 | ″ | ″ | system |
82 | ″ | ″ | theranostic formulations |
83 | ″ | ″ | theranostic nanomedicine |
84 | ″ | ″ | tract cancer |
85 | ″ | ″ | transferrin |
86 | ″ | ″ | transferrin receptor expression |
87 | ″ | ″ | treatment |
88 | ″ | ″ | tumor cells |
89 | ″ | ″ | vital organs |
90 | ″ | ″ | vivo |
91 | ″ | ″ | vivo data |
92 | ″ | ″ | weight |
93 | ″ | schema:name | A novel formulation of theranostic nanomedicine for targeting drug delivery to gastrointestinal tract cancer |
94 | ″ | schema:pagination | 26 |
95 | ″ | schema:productId | N3738cc8a412141e28a2524bd9b9d2b11 |
96 | ″ | ″ | N8e39b4b88e234693bb2ca572a3dd6756 |
97 | ″ | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1141763172 |
98 | ″ | ″ | https://doi.org/10.1186/s12645-021-00098-4 |
99 | ″ | schema:sdDatePublished | 2022-05-10T10:31 |
100 | ″ | schema:sdLicense | https://scigraph.springernature.com/explorer/license/ |
101 | ″ | schema:sdPublisher | Nfc98ae99ecd54ddcb207ecc8b164c890 |
102 | ″ | schema:url | https://doi.org/10.1186/s12645-021-00098-4 |
103 | ″ | sgo:license | sg:explorer/license/ |
104 | ″ | sgo:sdDataset | articles |
105 | ″ | rdf:type | schema:ScholarlyArticle |
106 | N02e44a52e8a0456193f6f274d93ec0fe | rdf:first | sg:person.015203065237.50 |
107 | ″ | rdf:rest | Nc7745464446247f6ba5c19fbbf1cf6e1 |
108 | N1206493e424342ddbbdef0ee868a0464 | schema:issueNumber | 1 |
109 | ″ | rdf:type | schema:PublicationIssue |
110 | N14986339aeb4400bb5a471bf1dfc7ee7 | rdf:first | N5d24e993783b48328e2415853aaaad2a |
111 | ″ | rdf:rest | N7d37da381d7b4e71976bfa12fd980edb |
112 | N1e51b0e4b74c46fbae690f0e7f9e1b5a | rdf:first | sg:person.012323352117.10 |
113 | ″ | rdf:rest | N3d4f5acdbefc467381b71eff1e6b5584 |
114 | N3738cc8a412141e28a2524bd9b9d2b11 | schema:name | dimensions_id |
115 | ″ | schema:value | pub.1141763172 |
116 | ″ | rdf:type | schema:PropertyValue |
117 | N3d4f5acdbefc467381b71eff1e6b5584 | rdf:first | sg:person.01215704533.26 |
118 | ″ | rdf:rest | N14986339aeb4400bb5a471bf1dfc7ee7 |
119 | N5d24e993783b48328e2415853aaaad2a | schema:affiliation | grid-institutes:grid.16821.3c |
120 | ″ | schema:familyName | Wang |
121 | ″ | schema:givenName | Heng |
122 | ″ | rdf:type | schema:Person |
123 | N79d7d0de8f644f939a085fc598e75466 | schema:volumeNumber | 12 |
124 | ″ | rdf:type | schema:PublicationVolume |
125 | N7d37da381d7b4e71976bfa12fd980edb | rdf:first | sg:person.0711767431.18 |
126 | ″ | rdf:rest | rdf:nil |
127 | N8e39b4b88e234693bb2ca572a3dd6756 | schema:name | doi |
128 | ″ | schema:value | 10.1186/s12645-021-00098-4 |
129 | ″ | rdf:type | schema:PropertyValue |
130 | Nc7745464446247f6ba5c19fbbf1cf6e1 | rdf:first | sg:person.015572452620.25 |
131 | ″ | rdf:rest | N1e51b0e4b74c46fbae690f0e7f9e1b5a |
132 | Nfc98ae99ecd54ddcb207ecc8b164c890 | schema:name | Springer Nature - SN SciGraph project |
133 | ″ | rdf:type | schema:Organization |
134 | anzsrc-for:11 | schema:inDefinedTermSet | anzsrc-for: |
135 | ″ | schema:name | Medical and Health Sciences |
136 | ″ | rdf:type | schema:DefinedTerm |
137 | anzsrc-for:1112 | schema:inDefinedTermSet | anzsrc-for: |
138 | ″ | schema:name | Oncology and Carcinogenesis |
139 | ″ | rdf:type | schema:DefinedTerm |
140 | sg:grant.8943040 | http://pending.schema.org/fundedItem | sg:pub.10.1186/s12645-021-00098-4 |
141 | ″ | rdf:type | schema:MonetaryGrant |
142 | sg:journal.1042272 | schema:issn | 1868-6958 |
143 | ″ | ″ | 1868-6966 |
144 | ″ | schema:name | Cancer Nanotechnology |
145 | ″ | schema:publisher | Springer Nature |
146 | ″ | rdf:type | schema:Periodical |
147 | sg:person.01215704533.26 | schema:affiliation | grid-institutes:grid.11173.35 |
148 | ″ | schema:familyName | Samra |
149 | ″ | schema:givenName | Zahoor Qadir |
150 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01215704533.26 |
151 | ″ | rdf:type | schema:Person |
152 | sg:person.012323352117.10 | schema:affiliation | grid-institutes:grid.440564.7 |
153 | ″ | schema:familyName | Aftab |
154 | ″ | schema:givenName | Saira |
155 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012323352117.10 |
156 | ″ | rdf:type | schema:Person |
157 | sg:person.015203065237.50 | schema:affiliation | grid-institutes:grid.440564.7 |
158 | ″ | schema:familyName | Lodhi |
159 | ″ | schema:givenName | Madeeha Shahzad |
160 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015203065237.50 |
161 | ″ | rdf:type | schema:Person |
162 | sg:person.015572452620.25 | schema:affiliation | grid-institutes:grid.440564.7 |
163 | ″ | schema:familyName | Khan |
164 | ″ | schema:givenName | Muhammad Tahir |
165 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015572452620.25 |
166 | ″ | rdf:type | schema:Person |
167 | sg:person.0711767431.18 | schema:affiliation | grid-institutes:grid.508161.b |
168 | ″ | schema:familyName | Wei |
169 | ″ | schema:givenName | Dong Qing |
170 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0711767431.18 |
171 | ″ | rdf:type | schema:Person |
172 | sg:pub.10.1038/srep21225 | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1019159708 |
173 | ″ | ″ | https://doi.org/10.1038/srep21225 |
174 | ″ | rdf:type | schema:CreativeWork |
175 | grid-institutes:grid.11173.35 | schema:alternateName | Institute of Biochemistry and Biotechnology, University of the Punjab, Lahore, Pakistan |
176 | ″ | schema:name | Institute of Biochemistry and Biotechnology, University of the Punjab, Lahore, Pakistan |
177 | ″ | rdf:type | schema:Organization |
178 | grid-institutes:grid.16821.3c | schema:alternateName | State Key Laboratory of Microbial Metabolism, School of Life Sciences and Biotechnology, Shanghai, China |
179 | ″ | schema:name | State Key Laboratory of Microbial Metabolism, School of Life Sciences and Biotechnology, Shanghai, China |
180 | ″ | rdf:type | schema:Organization |
181 | grid-institutes:grid.440564.7 | schema:alternateName | Institute of Molecular Biology and Biotechnology (IMBB), The University of Lahore, Defence Road Lahore, Postal code: 58810, Lahore, Pakistan |
182 | ″ | schema:name | Institute of Molecular Biology and Biotechnology (IMBB), The University of Lahore, Defence Road Lahore, Postal code: 58810, Lahore, Pakistan |
183 | ″ | rdf:type | schema:Organization |
184 | grid-institutes:grid.508161.b | schema:alternateName | Peng Cheng Laboratory, Vanke Cloud City Phase I Building 8, Xili Street, Nashan District, 518055, Shenzhen, Guangdong, People’s Republic of China |
185 | ″ | schema:name | Joint Laboratory of International Cooperation in Metabolic and Developmental Sciences, Ministry of Education, Shanghai Jiao Tong University, 200240, Shanghai, China |
186 | ″ | ″ | Peng Cheng Laboratory, Vanke Cloud City Phase I Building 8, Xili Street, Nashan District, 518055, Shenzhen, Guangdong, People’s Republic of China |
187 | ″ | ″ | State Key Laboratory of Microbial Metabolism, School of Life Sciences and Biotechnology, Shanghai, China |
188 | ″ | rdf:type | schema:Organization |